These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 4984503)

  • 41. Rifampicin and ethambutol in the treatment of drug resistant and far advanced pulmonary tuberculosis (with a note on capreomycin).
    Pines A; Raafat H; Siddiqui GM
    J Ir Med Assoc; 1970 Mar; 63(393):82-5. PubMed ID: 4984340
    [No Abstract]   [Full Text] [Related]  

  • 42. A clinical trial of ethambutol plus capreomycin in the treatment of atypical tuberculosis.
    Evans C; Thong KL
    Med J Aust; 1969 Oct; 2(15):744-8. PubMed ID: 4900530
    [No Abstract]   [Full Text] [Related]  

  • 43. Evaluation of capreomycin and ethambutol in retreatment of pulmonary tuberculosis.
    Lester W; Fischer DA; Dye WE
    Ann N Y Acad Sci; 1966 Apr; 135(2):890-903. PubMed ID: 5220244
    [No Abstract]   [Full Text] [Related]  

  • 44. Unilateral and painless development of isoniazid induced gynecomastia during re-treatment of pulmonary tuberculosis.
    Kumar L; Gupta R; Puri MM; Jaiswal A; Srinath ; Murar A; Behera D
    J Assoc Physicians India; 2011 Nov; 59():733-5. PubMed ID: 22616343
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [The relation between bacilli negative conversion rate and the number of combined sensitive antituberculous drugs in intermittent administration of rifampicin for severe pulmonary tuberculosis].
    Tamura M; Yamazaki A; Tamura T; Takano S; Yamazaki M
    Kekkaku; 1973 Jul; 48(7):297-302. PubMed ID: 4200058
    [No Abstract]   [Full Text] [Related]  

  • 46. [Endocavernous treatment of caverns with atypical Mycobacteria].
    Neef W
    Z Erkr Atmungsorgane Folia Bronchol; 1970 Jun; 131(5):385-9. PubMed ID: 5210837
    [No Abstract]   [Full Text] [Related]  

  • 47. The requirement of capreomycin, ethambutol and rifampicin in chronic pulmonary tuberculosis in Helsinki on the basis of resistance indications.
    Tani P
    Scand J Respir Dis Suppl; 1969; 69():15-6. PubMed ID: 4313500
    [No Abstract]   [Full Text] [Related]  

  • 48. [Reasons for chronic expectoration--case reports].
    Michałowska-Mitczuk D; Kuś J
    Pneumonol Alergol Pol; 1997; 65(3-4):244-8. PubMed ID: 9489422
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [On the effectiveness of rifampicin and ethambutol used in 3 different therapeutical schemes in drug-resistant chronic pulmonary tuberculosis].
    Andrian A; Ciobanu V; Cojocaru G; Borşaru I; Ciobanu D; Spirescu G; Roşianu D; Pescariu M
    Ftiziologia; 1971; 20(6):623-8. PubMed ID: 5162289
    [No Abstract]   [Full Text] [Related]  

  • 50. [Results of treatment of chronic pulmonary tuberculosis Mycobacterium in the sputum].
    Petrović B; Radović R; Petrović O; Arsenijević N; Jevdjić P; Jordanov S
    Tuberkuloza; 1967; 19(5):658-60. PubMed ID: 4971786
    [No Abstract]   [Full Text] [Related]  

  • 51. [Intermittent chemotherapy of chronic forms of pulmonary tuberculosis].
    Ershov AI; Tikhonov VA; Zheltukhina NI; Chesmochakova IV
    Probl Tuberk; 1976 Feb; (21):31-4. PubMed ID: 817283
    [No Abstract]   [Full Text] [Related]  

  • 52. Capreomycin compared with streptomycin in original treatment of pulmonary tuberculosis. XVI. A report of the Veterans Administration-Armed Forces Cooperative. Study on the Chemotherapy of Tuberculosis.
    Schwartz W
    Am Rev Respir Dis; 1966 Dec; 94(6):858-64. PubMed ID: 4958888
    [No Abstract]   [Full Text] [Related]  

  • 53. [Treatment of drug resistant chronic pulmonary tuberculosis with a number of tuberculostatics].
    Bernard E
    Bull Int Union Tuberc; 1968 Dec; 41():183-7. PubMed ID: 4303862
    [No Abstract]   [Full Text] [Related]  

  • 54. [Efficiency of interrupted therapy of tuberculosis (experimental study)].
    Drabkina RO; Ginzburg TS
    Antibiotiki; 1972 Jun; 17(6):555-60. PubMed ID: 5045922
    [No Abstract]   [Full Text] [Related]  

  • 55. Moxifloxacin versus ethambutol in the first 2 months of treatment for pulmonary tuberculosis.
    Burman WJ; Goldberg S; Johnson JL; Muzanye G; Engle M; Mosher AW; Choudhri S; Daley CL; Munsiff SS; Zhao Z; Vernon A; Chaisson RE
    Am J Respir Crit Care Med; 2006 Aug; 174(3):331-8. PubMed ID: 16675781
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Ethambutol and capreomycin in the re-treatment of advanced pulmonary tuberculosis.
    Lim BT; Aquinas M
    Am Rev Respir Dis; 1969 May; 99(5):792-3. PubMed ID: 4977179
    [No Abstract]   [Full Text] [Related]  

  • 57. Comparative studies of various antituberculosis drug regimens by means of serum antimycobacterial activity tests in man.
    Hokama S
    Jpn J Tuberc; 1967 Jul; 14(1):55-65. PubMed ID: 5300098
    [No Abstract]   [Full Text] [Related]  

  • 58. [Drug therapy of tuberculosis].
    Jentgens H
    Dtsch Med Wochenschr; 1974 Aug; 99(32):1627-30. PubMed ID: 4135677
    [No Abstract]   [Full Text] [Related]  

  • 59. [Four drug combination including Ethambutol and early switching to entirely new regimen in initial treatment of pulmonary tuberculosis].
    Kekkaku; 1970 Jul; 45(7):219-26. PubMed ID: 5449509
    [No Abstract]   [Full Text] [Related]  

  • 60. Surgical treatment of chronic infectious pulmonary tuberculosis without antituberculous chemotherapeutic cover.
    Mlekodaj S
    Pol Med J; 1971; 10(5):1173-8. PubMed ID: 5002489
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.